Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Stefanie Hauck"'
Autor:
Maren Marder, Caroline Remmert, Julius A. Perschel, Munkhtur Otgonbayar, Christine von Toerne, Stefanie Hauck, Judith Bushe, Annette Feuchtinger, Bilal Sheikh, Michel Moussus, Matthias Meier
Publikováno v:
Cell Reports, Vol 43, Iss 4, Pp 114008- (2024)
Summary: The metabolic syndrome is accompanied by vascular complications. Human in vitro disease models are hence required to better understand vascular dysfunctions and guide clinical therapies. Here, we engineered an open microfluidic vessel-on-chi
Externí odkaz:
https://doaj.org/article/a3ca716fe9f04c049613bc33c4f11518
Autor:
Simon I. Dreher, Paul Grubba, Alessia Moruzzi, Christine von Toerne, Thomas Goj, Andreas L. Birkenfeld, Andreas Peter, Stefanie Hauck, Peter Loskill, Cora Weigert
Publikováno v:
Diabetologie und Stoffwechsel.
Autor:
Jiudan Zhang, Elena Lalama, Kilian Alf Rüther, Bettina Schuppelius, Marta Csanalosi, Nicolle Kränkel, Stefan Kabisch, Andreas Buness, Svetozar Nesic, Agnese Petrera, Stefanie Hauck, Eicke Latz, Anette Christ, Andreas Pfeiffer
Publikováno v:
Diabetologie und Stoffwechsel.
Autor:
Thomas Goj, Miriam Hoene, Louise Fritsche, Patrick Schneeweiss, Jürgen Machann, Andreas Fritsche, Andreas L. Birkenfeld, Agnese Petrera, Stefanie Hauck, Andreas Peter, Martin Heni, Andreas M. Niess, Anja Moller, Cora Weigert
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Autor:
Nicole Schäfer, Antje Grosche, Joerg Reinders, Stefanie Hauck, Richard B. Pouw, Taco W. Kuijpers, Diana Wouters, Boris Ehrenstein, Volker Enzmann, Peter Zipfel, Christine Skerka, Diana Pauly
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
The human complement factor H-related protein-3 (FHR-3) is a soluble regulator of the complement system. Homozygous cfhr3/1 deletion is a genetic risk factor for the autoimmune form of hemolytic uremic syndrome (aHUS), whilst also found to be protect
Externí odkaz:
https://doaj.org/article/aca3d5f5edaa4e228d242b2ec4b43654
Autor:
Sevgican Demir, Gretchen Wolff, Annika Wieder, Adriano Maida, Marco Rahm, Martina Schnölzer, Stefanie Hauck, Julia Szendrödi, Stephan Herzig, Bilgen Ekim Üstünel
Transforming Growth Factor β 1 Stimulated Clone 22 D4 (TSC22D4) is an intrinsically disordered protein that regulates cellular and physiological processes such as cell proliferation, cellular senescence as well as hepatic glucose and lipid metabolis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5faf8f4624f8b415bb45821713bf414
https://doi.org/10.1101/2021.12.20.473554
https://doi.org/10.1101/2021.12.20.473554
Autor:
Fani Ziouti, Krystyna Albrecht, Laura Mainz, Markus Sauer, Ilona Zilkowski, Stefanie Schmidt, Franziska Jundt, Stefanie Hauck, Jürgen Groll, Andres Schulze
Publikováno v:
Biomacromolecules. 20:916-926
Multiple myeloma is a common plasma-cell-derived hematologic neoplasm. While the delivery of growth-inhibiting miRNA to multiple myeloma cells would be a promising strategy to evaluate treatment options, most multiple myeloma cells are transfection-r
Autor:
Stefanie Hauck, Sabrina Khageh Hosseini, Kerstin Hiesinger, Janosch Achenbach, Ewgenij Proschak, Martin Zörnig, Ricardo M. Biondi, Dalibor Odadzic
The transcriptional regulator FUSE binding protein 1 (FUBP1) is aberrantly upregulated in various malignancies, fulfilling its oncogenic role by the deregulation of critical genes involved in cell cycle control and apoptosis regulation. Thus, the pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::671188aeccd42a1251c356af5aa21257
https://www.sciencedirect.com/science/article/pii/S0968089616307027
https://www.sciencedirect.com/science/article/pii/S0968089616307027
Autor:
Maria A. Gonzalez-Carmona, Jörg O. Schulze, Stephan Zangos, Stefan Zeuzem, Jörg Trojan, Sabrina Khageh Hosseini, Martin Zörnig, Dieter Steinhilber, Stefanie Hauck, A Vogt, Josephine Wesely, Thomas J. Vogl, Eugen Proschak, Christian P. Strassburg, Ricardo M. Biondi
Publikováno v:
Cancer Research. 76:B39-B39
Hepatocellular carcinoma (HCC) is the most common form of liver cancer. It is accounting for one million deaths per year, mostly due to the late time point of diagnosis and especially to the lack of a specified therapy. In more than 90% of HCCs the o
Autor:
Jörg O. Schulze, Jörg Trojan, Stephan Zangos, Josephine Wesely, Ricardo M. Biondi, Stefanie Hauck, Stefan Zeuzem, Eugen Proschak, Volker Gatterdam, S. Khageh Hosseini, Oliver Waidmann, Martin Zörnig, Dieter Steinhilber, Steffen Hahn, Katharina Gerlach
Publikováno v:
European Journal of Cancer. 69:S18